Gershon AS

References (2)

Title : Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: a cohort study - Thompson_2025_BMJ.Open.Diabetes.Res.Care_13_
Author(s) : Thompson W , Yu B , Porter J , Fang J , Ferreira-Legere LE , Austin PC , Jackevicius CA , Ross H , Lee DS , Weisman A , Farkouh ME , Gershon AS , Atzema CL , Kwong JC , Ha A , Dzavik V , Udell JA
Ref : BMJ Open Diabetes Res Care , 13 : , 2025
Abstract :
PubMedSearch : Thompson_2025_BMJ.Open.Diabetes.Res.Care_13_
PubMedID: 40780839

Title : Cholinesterase inhibitors and adverse pulmonary events in older people with chronic obstructive pulmonary disease and concomitant dementia: a population-based, cohort study - Stephenson_2012_Drugs.Aging_29_213
Author(s) : Stephenson A , Seitz DP , Fischer HD , Gruneir A , Bell CM , Gershon AS , Fu L , Anderson GM , Austin PC , Rochon PA , Gill SS
Ref : Drugs & Aging , 29 :213 , 2012
Abstract :
PubMedSearch : Stephenson_2012_Drugs.Aging_29_213
PubMedID: 22332932